1181 – 1190 of 1570
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
COMP acts as a catalyst in collagen fibrillogenesis
(
- Contribution to journal › Article
- 2006
-
Mark
Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab
(
- Contribution to journal › Article
-
Mark
Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
-
Mark
Extracellular matrix in disc degeneration.
(
- Contribution to journal › Article
-
Mark
Chondroitin sulfate perlecan enhances collagen fibril formation - Implications for perlecan chondrodysplasias
(
- Contribution to journal › Article
-
Mark
The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis
(
- Contribution to journal › Article
-
Mark
Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden
(
- Contribution to journal › Article
-
Mark
The LUNDEX, a new index of drug efficacy in clinical practice: results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden.
(
- Contribution to journal › Article
-
Mark
Mortality in systemic lupus erythematosus
(
- Contribution to journal › Article
-
Mark
Polarized subsets of human T-helper cells induce distinct patterns of chemokine production by normal and systemic sclerosis dermal fibroblasts
(
- Contribution to journal › Article